Abbott Laboratories (XSWX:ABT) Buildings And Improvements: CHF0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:ABT Abbott Laboratories XSWX:ABT
80 GF Score
Price CHF91.50
GF Value CHF105.67
! 2 Warning Signs
View Full Analysis

What is Abbott Laboratories Buildings And Improvements?

Abbott Laboratories XSWX:ABT +0.55% 80 Buildings And Improvements is CHF0 Mil as of Jun. 2026. GuruFocus rates XSWX:ABT with a GF Score™ of 80/100 and a GF Value™ of CHF105.67. The stock has 2 warning signs investors should review.

Abbott Laboratories's quarterly buildings and improvements declined from Dec. 2025 (CHF3,620 Mil) to Mar. 2026 (CHF0 Mil) but then stayed the same from Mar. 2026 (CHF0 Mil) to Jun. 2026 (CHF0 Mil).

Abbott Laboratories's annual buildings and improvements increased from Dec. 2023 (CHF3,598 Mil) to Dec. 2024 (CHF3,751 Mil) but then declined from Dec. 2024 (CHF3,751 Mil) to Dec. 2025 (CHF3,620 Mil).

Abbott Laboratories Buildings And Improvements Historical Data

* Premium members only.

The historical data trend for Abbott Laboratories's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abbott Laboratories Buildings And Improvements Chart

Abbott Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buildings And Improvements
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,690.45 3,775.78 3,598.43 3,750.96 3,620.32

Abbott Laboratories Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Buildings And Improvements Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 3,620.32 0.00 0.00
XSWX:ABT
80GF Score
Abbott Laboratories XSWX:ABT
Buildings And Improvements is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abbott Laboratories Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction.  Broker and architect fees, permits, etc. can be covered within this category.  Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized.  Improvements are commonly recorded at acquisition cost.  Building improvement examples include roofing, remodeling, replacements, etc.

What does a Buildings And Improvements of CHF0 Mil mean?
Abbott Laboratories (XSWX:ABT) has a Buildings And Improvements of CHF0 Mil as of Jun. 2026. Buildings and improvements is the total value of a company's buildings and improvements to them. View historical data on Abbott Laboratories and its competitors.
Is Abbott Laboratories' Buildings And Improvements too high?
Abbott Laboratories' current Buildings And Improvements is CHF0 Mil. Overall, Abbott Laboratories has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Abbott Laboratories' Buildings And Improvements compare to SYK and MDT?
Abbott Laboratories' Buildings And Improvements of CHF0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buildings And Improvements for a Medical Devices & Instruments company?
A good Buildings And Improvements depends on the Medical Devices & Instruments industry context. However, Buildings And Improvements should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buildings And Improvements mean?
A high Buildings And Improvements can signal that a stock is expensive relative to its fundamentals. Buildings and improvements is the total value of a company's buildings and improvements to them. View historical data on Abbott Laboratories and its competitors. Abbott Laboratories's current Buildings And Improvements is CHF0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott Laboratories stock overvalued right now?
Abbott Laboratories (XSWX:ABT) has a current Buildings And Improvements of CHF0 Mil. The stock's GF Value™ is CHF105.67, compared to a current price of CHF91.50 — trading 13.4% below its estimated fair value. The current Buildings And Improvements is CHF0 Mil. Abbott Laboratories' overall GF Score™ is 80/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buildings And Improvements calculated?
Buildings And Improvements is calculated from a company's financial statements. For Abbott Laboratories (XSWX:ABT), the current Buildings And Improvements is CHF0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Abbott Laboratories (XSWX:ABT) Overvalued in 2026?

Based on GuruFocus' analysis, Abbott Laboratories stock appears to be undervalued. The current stock price of CHF91.50 is trading 13.4% below its estimated GF Value™ of CHF105.67.

Key valuation signals for XSWX:ABT:

  • Buildings And Improvements: CHF0 Mil
  • GF Value™: CHF105.67 vs. price of CHF91.50 (13.4% below fair value)
  • GF Score™: 80/100 with 2 warning signs

No single metric tells the full story. See the XSWX:ABT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Abbott Laboratories Business Description

Address 100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
80GF Score

Get the complete analysis for XSWX:ABT

Buildings And Improvements is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF91.50
Price
CHF105.67
GF Value